{"Title": "The management of peyronie\u2019s disease", "Year": 2017, "Source": "Surgical Procedures for Core Urology Trainees", "Volume": null, "Issue": null, "Art.No": null, "PageStart": 119, "PageEnd": 133, "CitedBy": 0, "DOI": "10.1007/978-3-319-57442-4_14", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85042601072&origin=inward", "Abstract": "\u00a9 Springer International Publishing AG 2018.Peyronie\u2019s disease (PD) was first described by Francois de la Peyronie (1678-1747), who reported a series of patients with \u201crosary beads of scar tissue\u201d causing curvature of the penis. Peyronie\u2019s Disease is an acquired benign fibrotic disorder involving the tunica albuginea (TA) of the corpora cavernosa of the penis leading to the formation of fibrous inelastic plaques [1]. Peyronie\u2019s Disease is believed to occur in the genetically susceptible individuals and is associated with penile curvature, pain and worsening of erectile function. Peyronie\u2019s Disease has an estimated prevalence of 3-9% in adult men and is frequently associated with cardiovascular risk factors including diabetes, hypertension, dyslipidaemia, and low serum testosterone levels [2-5].", "AuthorKeywords": null, "IndexKeywords": null, "DocumentType": "Book", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-85042601072", "SubjectAreas": [["Medicine (all)", "MEDI", "2700"]], "AuthorData": {"36702681800": {"Name": "Castiglione F.", "AuthorID": "36702681800", "AffiliationID": "60024544", "AffiliationName": "Department of Urology, The Institute of Urology, University College London Hospitals"}, "55781298300": {"Name": "Ralph D.J.", "AuthorID": "55781298300", "AffiliationID": "60024544", "AffiliationName": "Department of Urology, The Institute of Urology, University College London Hospitals"}, "24474853700": {"Name": "Garaffa G.", "AuthorID": "24474853700", "AffiliationID": "60024544", "AffiliationName": "Department of Urology, The Institute of Urology, University College London Hospitals"}}}